Company Overview
About Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with paralysis to control digital devices directly with their thoughts. The company's first commercial product, the N1 implant, is a coin-sized device containing 1,024 electrodes that is surgically placed in the motor cortex. As of September 2025, twelve patients worldwide had received the N1 implant and were actively using it to control computers, smartphones, and robotic arms with neural signals alone.
Business Model & Competitive Advantage
Neuralink has raised approximately $1.85 billion in total primary funding, including a $600M raise in May 2025 at a $9.6B valuation and a $650M Series E in April 2026 led by ARK Invest, Sequoia Capital, Founders Fund, Lightspeed, and Thrive Capital, bringing the valuation to approximately $14.9B. The company has transitioned from R&D-stage manufacturing to commercial-scale operations, with Elon Musk indicating high-volume production is targeted for 2026. Initial regulatory clearance from the FDA covers the device for restoring motor function in paralysis patients, with future indications planned for blindness restoration and psychiatric conditions.
Competitive Landscape 2025–2026
Neuralink's long-term vision extends well beyond medical applications: Musk has stated the goal is to achieve a "symbiosis" between humans and artificial intelligence, enabling cognitive enhancement for non-disabled individuals. The company faces competition from Synchron (which uses a less invasive stent-based approach already deployed in patients) and academic research groups, but holds the most advanced implant design in terms of electrode count, wireless bandwidth, and long-term signal stability. Its path to mass-market adoption depends on regulatory expansion, surgical scalability, and demonstrated long-term device durability.
Key Differentiators
Market Leader
Neuralink is recognized as a market leader in the Life Sciences & BioTech sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
Saama Analytics
Saama Analytics is the leading AI-driven clinical analytics and data management platform for the life sciences industry, positioning itself as the "#1 in AI Clinical Analytics" based on customer adopt
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Compare Neuralink with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Neuralink? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Neuralink Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Neuralink vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →